Dag Hammarskjölds väg 52 A
Uppsala 752 37
Sweden
46 1 84 44 36 10
https://qlinea.com
Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 127
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Stuart Gander | Chief Executive Officer | N/A | N/A | 1978 |
Mr. Christer Samuelsson | CFO & IR | N/A | N/A | 1962 |
Mr. Henrik Jacobson | Chief Operating Officer | N/A | N/A | 1969 |
Ms. Ulrika Stolpe | HR Manager | N/A | N/A | 1967 |
Ms. Tiziana Di Martino | Chief Medical Officer | N/A | N/A | 1976 |
Mr. Thomas Fritz | Chief Commercial Officer | N/A | N/A | 1964 |
Mr. Anders Ljunggren | Managing Director | N/A | N/A | 1981 |
Ms. Victoria Lerneryd | Manager of QA/RA | N/A | N/A | 1984 |
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. It offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. The company serves healthcare providers. Q-linea AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden.
Q-linea AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.